Health and Me

Ishita Roy

FDA Approves Dupixent For Chronic Spontaneous Urticaria In Adolescents And Adults

FDA Approves Dupixent for Chronic Spontaneous Urticaria in Adolescents and Adults

The <span>US Food and Drug Administration</span> (FDA) has granted approval to <span>Dupixent</span> or dupilumab for the treatment of chronic spontaneous urticaria (CSU) in adults and adolescents who are aged 12 years or are older. The approval caters to those who would have to continue to experience symptoms despite being on histmamine-1 (H1) antihistamine therapy. These are medications that block the effects of histamine on H1 receptors and are primarily used to treat allergies or allergic reactions. 

It is a biologic medication which targets specific pathways in the immune system. It is a monoclonal antibody, which is designed to inhibit the signaling of two key proteins, namely: interleukin-4 (IL-4) and interleukin-13 (IL-13). These two play a central role in type 2 inflammation, which is believed to contribute to a variety of allergic and inflammatory conditions. It is also approved for other conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. 

<h4>What is Chronic Spontaneous Urticaria?</h4>

As per the 2017 study published in Canadian Medical Association Journal, titled Chronic spontaneous urticaria, the condition is defined by the presence of hives daily or almost for at lease six weeks. The study also mentions that the condition mostly affects the working population and may have a substantial impact on quality of life.

As per the American College of Allergy, Asthma &amp; Immunology, it affects about 20% of people at some time during their lives. It can also be triggered by many substances or situations and usually starts as an itchy patch of skin that turns into swollen red welts. 

Rarely, cases of hives last more than six weeks and could end up staying for up to 5 years. This condition is known as chronic spontaneous urticaria or idiopathic urticaria. It can affect 1.4% of the general population and is seen in women twice as commonly as men. 

For many individuals, the condition is both physically uncomfortable and emotionally distressing, often interfering with sleep, daily activities, and overall quality of life. In some patients, standard antihistamines fail to control the symptoms, leaving them in need of more effective treatment options.

The FDA has based its decision on the results of two phase 3 clinical trials that studied the drug ass an add-on to the standard antihistamine therapy. The trials also included patients who had not previously been treated with biologic therapies and who continued to show symptoms despite being on antihistamines. 

In both studies, Dupixent met its primary and key secondary endpoints. Patients receiving the medication showed a significant reduction in the severity of itching and urticaria activity after 24 weeks, compared to those who received placebo plus antihistamines. Additionally, those on Dupixent were more likely to achieve well-controlled disease or a complete response by the end of the study period. The safety profile observed in these trials was consistent with what has already been documented in other approved uses of Dupixent.

The approval of Dupixent for CSU represents a significant advancement for patients and healthcare providers. It offers new hope for those who have been living with poorly controlled symptoms, enhancing their ability to manage the condition more effectively and improve overall quality of life.

Health Conditions A-Z

health

fda-approves-dupixent-for-chronic-spontaneous-urticaria-in-adolescents-and-adults

dupixent

us food and drug administration

health news

health news us

us health news

USA health news

tiny-stones-big-pain-how-modern-endoscopy-is-saving-salivary-glands

Tiny Stones, Big Pain: How Modern Endoscopy Is Saving Salivary Glands

hpv-vaccine

Cervical Cancer Prevention: Why HPV Vaccine Matters More Than Ever

vaping-cancer-risk-emerging-evidence-raises-serious-health-concerns-12-noon

Vaping And Cancer Risk: Emerging Evidence Raises Serious Health Concerns

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The US Food and Drug Administration (FDA) has granted approval to Dupixent or dupilumab for the treatment of chronic spontaneous urticaria (CSU) in adults and adolescents who are aged 12 years or are older. The approval caters to those who would have to continue to experience symptoms despite being on histmamine-1 (H1) antihistamine therapy. These are medications that block the effects of histamine on H1 receptors and are primarily used to treat allergies or allergic reactions. What is Dupixent?It is a biologic medication which targets specific pathways in the immune system. It is a monoclonal antibody, which is designed to inhibit the signaling of two key proteins, namely: interleukin-4 (IL-4) and interleukin-13 (IL-13). These two play a central role in type 2 inflammation, which is believed to contribute to a variety of allergic and inflammatory conditions. It is also approved for other conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. What is Chronic Spontaneous Urticaria?As per the 2017 study published in Canadian Medical Association Journal, titled Chronic spontaneous urticaria, the condition is defined by the presence of hives daily or almost for at lease six weeks. The study also mentions that the condition mostly affects the working population and may have a substantial impact on quality of life.As per the American College of Allergy, Asthma & Immunology, it affects about 20% of people at some time during their lives. It can also be triggered by many substances or situations and usually starts as an itchy patch of skin that turns into swollen red welts. Rarely, cases of hives last more than six weeks and could end up staying for up to 5 years. This condition is known as chronic spontaneous urticaria or idiopathic urticaria. It can affect 1.4% of the general population and is seen in women twice as commonly as men. For many individuals, the condition is both physically uncomfortable and emotionally distressing, often interfering with sleep, daily activities, and overall quality of life. In some patients, standard antihistamines fail to control the symptoms, leaving them in need of more effective treatment options.How Was Dupixent Approved?The FDA has based its decision on the results of two phase 3 clinical trials that studied the drug ass an add-on to the standard antihistamine therapy. The trials also included patients who had not previously been treated with biologic therapies and who continued to show symptoms despite being on antihistamines. In both studies, Dupixent met its primary and key secondary endpoints. Patients receiving the medication showed a significant reduction in the severity of itching and urticaria activity after 24 weeks, compared to those who received placebo plus antihistamines. Additionally, those on Dupixent were more likely to achieve well-controlled disease or a complete response by the end of the study period. The safety profile observed in these trials was consistent with what has already been documented in other approved uses of Dupixent.The approval of Dupixent for CSU represents a significant advancement for patients and healthcare providers. It offers new hope for those who have been living with poorly controlled symptoms, enhancing their ability to manage the condition more effectively and improve overall quality of life.

fda approves dupixent for chronic spontaneous urticaria in adolescents and adults

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

FDA Approves Dupixent For Chronic Spontaneous Urticaria In Adolescents And Adults

NASA’s Artemis II Mission To Test Human Health in Deep Space

COVID Cicada Variant Unlikely To Pose Major Threat, Claims Study

India Passes Jan Vishwas Bill: Here’s How It Decriminalizes Health Sector, Boosts Compliance

Health Conditions A-Z

Tiny Stones, Big Pain: How Modern Endoscopy Is Saving Salivary Glands

Cervical Cancer Prevention: Why HPV Vaccine Matters More Than Ever

Vaping And Cancer Risk: Emerging Evidence Raises Serious Health Concerns